The pharmacokinetics and pharmacodynamics of alogliptin in children, adolescents, and adults with type 2 diabetes mellitus - Dudkowski, Caroline; Tsai, Max; Liu, Jie; Zhao, Zhen; Schmidt, Eric; Xie, Jeannie (European journal of clinical pharmacology, 2017)
Keywords: Adolescent; Adult; Area Under Curve; Biomedical and Life Sciences; Biomedicine; Child; Clinical Trial; Diabetes Mellitus, Type 2 - drug therapy; Diabetes Mellitus, Type 2 - metabolism; Dipeptidyl-Peptidase IV Inhibitors - adverse effects; Dipeptidyl-Peptidase IV Inhibitors - pharmacokinetics; Dipeptidyl-Peptidase IV Inhibitors - pharmacology; Dipeptidyl-Peptidase IV Inhibitors - therapeutic use; Female; Half-Life; Humans; Hypoglycemic Agents - adverse effects; Hypoglycemic Agents - pharmacokinetics; Hypoglycemic Agents - pharmacology; Hypoglycemic Agents - therapeutic use; Kinetics; Male; Pediatrics; Pharmacology; Pharmacology/Toxicology; Piperidines - adverse effects; Piperidines - pharmacokinetics; Piperidines - pharmacology; Piperidines - therapeutic use; Studies; Uracil - adverse effects; Uracil - analogs & derivatives; Uracil - pharmacokinetics; Uracil - pharmacology; Uracil - therapeutic use; Young Adult; Alogliptin; Pharmacodynamics; Pharmacokinetics; Pediatric patients; DPP-4 inhibition